CMS STATEMENT: Delay in Final Chimeric Antigen Receptor (CAR) T-cell therapy National Coverage Determination
May 17, 2019 | Coverage
Delay in Final Chimeric Antigen Receptor (CAR) T-cell therapy National Coverage Determination
From a CMS spokesperson:
“CMS will not be issuing a final National Coverage Determination on CAR T-cell therapy for cancer today, but a decision is forthcoming.”
To read the proposed decision, visit the CMS website at:
Comments may be viewed in their entirety by using the following link:
Get CMS news at cms.gov/newsroom, sign up for CMS news via email and follow CMS on Twitter CMS Administrator @SeemaCMS, @CMSgov, and @CMSgovPress.
GET IN TOUCH
© Copyright 2019 | iCURE, LLC.
445 Minnesota St., Suite #1500
Saint Paul, MN 55101